After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VRTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Vertex Pharmaceuticals, Inc is $109.11B. A total of 1.5 million shares were traded on the day, compared to an average of 1.83M shares.
In the most recent transaction, Biller Jonathan sold 694 shares of VRTX for 404.21 per share on Oct 02 ’25. After the transaction, the EVP and Chief Legal Officer now owns 15,653 company shares. In a previous transaction on Oct 02 ’25, Biller Jonathan bought 694 shares at 404.21 per share.
Among the insiders who sold shares, Bhatia Sangeeta N. disposed of 266 shares on Aug 27 ’25 at a per-share price of $386.69. This resulted in the Director holding 4,565 shares of VRTX after the transaction. In another insider transaction, Bhatia Sangeeta N. bought 266 shares at $386.69 per share on Aug 27 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VRTX has a high of $519.88 and a low of $362.50.
As of this writing, VRTX has an earnings estimate of $4.58 per share for the current quarter. EPS was calculated based on a consensus of 22.0 estimates, with a high estimate of $5.01 per share and a lower estimate of $4.2. The company reported an EPS of $4.38 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $67.01, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.06.
